Management of Dyslipidaemias
- 1 February 2000
- journal article
- Published by Springer Nature in Disease Management and Health Outcomes
- Vol. 7 (2) , 83-109
- https://doi.org/10.2165/00115677-200007020-00004
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein CholesterolNew England Journal of Medicine, 1999
- Primary Prevention of Coronary Heart Disease: Guidance From FraminghamCirculation, 1998
- Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)BMJ, 1998
- Fasting Triglycerides, High-Density Lipoprotein, and Risk of Myocardial InfarctionCirculation, 1997
- EUROASPIRE: A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal resultsEuropean Heart Journal, 1997
- Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged menThe American Journal of Cardiology, 1996
- National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).Circulation, 1994
- Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia AssociationPublished by Oxford University Press (OUP) ,1993
- Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention TrialDiabetes Care, 1993
- High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.Circulation, 1989